Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2026-01-03 @ 8:44 PM
Study NCT ID:
NCT00626795
Status:
COMPLETED
Last Update Posted:
2025-03-12
First Post:
2008-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
Sponsor:
LEO Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-21
First Submit QC Date:
None
Study First Post Date:
2008-02-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-26
Results First Submit QC Date:
None
Results First Post Date:
2018-07-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-03-12
Last Update Post Date Type:
ACTUAL